After Republicans and Democrats failed to compromise on the budget bill, money to US federal agencies has officially been cut off. Donald Trump threatens “irreversible cuts”. The gaping security flaw…
Published on 3 months ago
After pressure from US President Donald Trump, Israel’s Prime Minister Bibi Netanyahu has been strong-armed into agreeing a deal for Gaza. Will Hamas sign up too? Our correspondent analyses the path …
Published on 3 months ago
The collapse of Russia’s wartime economy has long been foretold, yet massive fiscal stimulus has compensated for the effect of sanctions. Though the pinch is now being felt, the labour market is surp…
Published on 3 months ago
President Donald Trump’s executive order ostensibly puts a years-long debate to bed. But questions persist about who will own—and influence—TikTok’s American operations. We examine the evidence on ho…
Published on 3 months, 1 week ago
A snapshot of the country reveals deepening military and economic problems—and, perhaps above all, political ones. America’s efforts to clamp down on skilled-worker visas will have far-reaching unint…
Published on 3 months, 1 week ago
A long-suspected defence partnership between Saudi Arabia and Pakistan has burst into the open. We ask what Pakistan’s extension of its nuclear umbrella will mean. As Chinese brands sweep the world, …
Published on 3 months, 1 week ago
Coffers running low and an increasingly absent principal member: the United Nations has never looked so precarious. We discuss its future amid uncertain geopolitics. The generative-AI explosion has m…
Published on 3 months, 1 week ago
Part commemoration, part megachurch meeting, largely political rally—the memorial service for Charlie Kirk revealed much about how the Trump administration intends to respond to his killing. Sunlight…
Published on 3 months, 1 week ago
India is becoming one of the largest markets for Artificial Intelligence and shaping how the technology develops. Our correspondent assesses what type of AI superpower the country could be. Tracking …
Published on 3 months, 2 weeks ago
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous …
Published on 3 months, 2 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate